Oncolytic Virus Review Articles:

 In recent years, there has been an explosion within the variety of immune-oncology medicine approved or in development for cancer treatment, and a few of those therapies have demonstrated objective responses not seen with little molecules (1–3). Clinical trials testing immune-oncology agents alone and in combo’s area unit well current and plenty of those combination drug trials are shown to boost patient overall survival over monotherapies (4,5). during this review, we tend to specialise in a promising category of immune-oncology drugs, oncolytic viruses (OVs) that area unit replicating viruses built to own neoplasm selective killing activity. we are going to initial summary cancer treatment from a historical perspective, followed by a quick history of oncolytic virotherapy, style of terrorist group, and specialise in some of the viruses presently in clinical testing. we tend to apologize to our colleagues whose primary work we tend to couldn't cite because of house constraints and instead have mentioned excellent reviews revealed.